Specht L, Hansen M M, Geisler C
Scand J Haematol. 1984 Mar;32(3):265-70. doi: 10.1111/j.1600-0609.1984.tb01691.x.
16 young women in long-term remission after first-line treatment for the early stages of Hodgkin's disease were examined for ovarian function 48 to 125 months after termination of therapy. The patients had received mantle field irradiation, plus either irradiation of infradiaphragmatic lymph nodes or 6 cycles of MOPP. 4 patients showed signs of ovarian failure judged by menopausal symptoms, menstrual pattern and/or hormone values. 12 patients had functioning ovaries; 8 of these had become pregnant after treatment, 2 had had an induced abortion, and 7 had given birth to a total of 9 healthy babies after treatment. The patients with signs of ovarian failure were older than the others, but the difference was not statistically significant. No difference between the patients who had received different treatments was established, nor does the study confirm the proposed protective effect of oral contraceptives. For women under 35 years of age, the long-term chances of preserving ovarian function after standard treatment for the lower stages of Hodgkin's disease seem to be much better than hitherto assumed.
对16名在接受一线治疗后处于霍奇金病早期长期缓解状态的年轻女性,在治疗结束后48至125个月对其卵巢功能进行了检查。这些患者接受了斗篷野照射,加膈下淋巴结照射或6个周期的MOPP方案。根据更年期症状、月经模式和/或激素值判断,4名患者出现卵巢功能衰竭迹象。12名患者卵巢功能正常;其中8名在治疗后怀孕,2名进行了人工流产,7名在治疗后共生下9名健康婴儿。有卵巢功能衰竭迹象的患者比其他患者年龄大,但差异无统计学意义。接受不同治疗的患者之间未发现差异,该研究也未证实口服避孕药的预期保护作用。对于35岁以下的女性,霍奇金病较低分期标准治疗后保留卵巢功能的长期几率似乎比迄今所认为的要好得多。